A Phase 1 Study of D3S-003 as Monotherapy in Participants With Advanced Solid Tumors With a KRAS p.G12D Mutation.
Clinical trial NCT07456046 · RECRUITING
Trial details
- NCT number
- NCT07456046
- Sponsor
- D3 Bio (Wuxi) Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-29
- Primary completion
- 2028-01-11
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.